Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 498581 - 498600 out of 505060 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (A16AB02) imiglucerase (adm: P) | CEREZYME 400UNT/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gaucher Disease | GenzymeCorporation |
| USA | (A16AB02) imiglucerase (adm: P) | CEREZYME 400UNT/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Gaucher Disease | GenzymeCorporation |
| USA | (A16AB04) agalsidase beta (adm: P) | FABRAZYME 35MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Fabry Disease | GenzymeCorporation |
| USA | (A16AB04) agalsidase beta (adm: P) | FABRAZYME 35MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Fabry Disease | GenzymeCorporation |
| USA | (A16AB04) agalsidase beta (adm: P) | FABRAZYME 5MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Fabry Disease | GenzymeCorporation |
| USA | (A16AB04) agalsidase beta (adm: P) | FABRAZYME 5MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Fabry Disease | GenzymeCorporation |
| USA | (A16AB05) laronidase (adm: P) | ALDURAZYME 2.9MG/5ML INJ VIAL | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Mucopolysaccharidosis I | GenzymeCorporation |
| USA | (A16AB05) laronidase (adm: P) | ALDURAZYME 2.9MG/5ML INJ VIAL | 5ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Mucopolysaccharidosis I | GenzymeCorporation |
| USA | (A16AB07) alglucosidase alfa (adm: P) | LUMIZYME 50MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenzymeCorporation |
| USA | (A16AB07) alglucosidase alfa (adm: P) | LUMIZYME 50MG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenzymeCorporation |
| USA | (A16AB25) olipudase alfa (adm: P) | XENPOZYME 20MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Acid sphingomyelinase deficiency (ASMD) type A/B or type B | GenzymeCorporation |
| USA | (A16AB25) olipudase alfa (adm: P) | XENPOZYME 20MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Acid sphingomyelinase deficiency (ASMD) type A/B or type B | GenzymeCorporation |
| USA | (A16AB25) olipudase alfa (adm: P) | XENPOZYME 4MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Acid sphingomyelinase deficiency (ASMD) type A/B or type B | GenzymeCorporation |
| USA | (A16AB25) olipudase alfa (adm: P) | XENPOZYME 4MG/VIAL INJ,LYPHL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Acid sphingomyelinase deficiency (ASMD) type A/B or type B | GenzymeCorporation |
| USA | (A16AX) various alimentary tract and metabolism products | RIVFLOZA 128MG/0.8ML INJ,SOLN SYRINGE | 0.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovoNordiskInc. |
| USA | (A16AX) various alimentary tract and metabolism products | RIVFLOZA 128MG/0.8ML INJ,SOLN SYRINGE | 0.8ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovoNordiskInc. |
| USA | (A16AX03) sodium phenylbutyrate (adm: O) | BUPHENYL 250GM | 250GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HORIZONTHERAPEUTICSUSA,INC. |
| USA | (A16AX03) sodium phenylbutyrate (adm: O) | BUPHENYL 250GM | 250GM | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HORIZONTHERAPEUTICSUSA,INC. |
| USA | (A16AX03) sodium phenylbutyrate (adm: O) | BUPHENYL 500MG TAB | 250 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HORIZONTHERAPEUTICSUSA,INC. |
| USA | (A16AX03) sodium phenylbutyrate (adm: O) | BUPHENYL 500MG TAB | 250 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | HORIZONTHERAPEUTICSUSA,INC. |
Pages
